View PDF Version - RePub - Erasmus Universiteit Rotterdam
View PDF Version - RePub - Erasmus Universiteit Rotterdam
View PDF Version - RePub - Erasmus Universiteit Rotterdam
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
INTRODUCTION<br />
To counteract the deleterious effects of mutagenic and. carcinogenic agents, organisms<br />
are equipped. with a sophisticated network of DNA repair systems. Nucleotide excision<br />
repair (NER), one of the best studied DNA repair pathways, removes a wide diversity<br />
of lesions, including cyclobutane pyrimidine dimers and (6-4) photoproducts (induced<br />
by VV-light), as well as numerous chemical adducts. The consequences of inborn<br />
errors in NER are highlighted by the rare autosomal recessive repair syndromes<br />
xeroderma pigmentosum (XP), Cockayne syndrome (CS) and trichothiodystrophy<br />
(TID). Complementation tests by cell fusion have demonstrated that the NER<br />
syndromes are genetically heterogeneous and. comprise at least 10 complementation<br />
groups: 7 in XP (XP-A to XP-G), 2 in the classical form of CS (CS-A and -B) and one<br />
ill TID (TID-A), whereas two TID complementation groups are simultaneously XP<br />
groups (XP-B and XP-D) (I, for a recent review).<br />
XP patients display sunsensitivity, pigmentation abuOlmalities in sun-exposed areas,<br />
frequently accelerated neurodegeneration and are predisposed to develop skin cancer.<br />
The halhnarks of CS are sunsensitivity, severe mental and physical retardation, skeletal<br />
abnonnalities and a wizened facial appearance. The mental dysfunction in CS is due to<br />
lleurodysmyelination (2). In XP complementation groups B, -D and -G, some patients<br />
show combined features of XP and CS. TID is characterized by sulphur-deficient<br />
brittle hair and nails, ichthyotic skin, as well as impaired growth and<br />
lleurodysmyelination like in CS (3). Moreover, approximately 70% of the TID patients<br />
show a NER defect that in most cases is caused by mutations in the XPD gene<br />
(previously referred to as ERCC2) (4, 5). Remarkably, CS patients as well as TTD<br />
patients with a defect in NER are not cancerprone.<br />
XPD was found to be identical to the p80 subunit of basal transcription factor TFIIH,<br />
involved in transcription initiation of RNA pol II transcribed genes (6). Furthermore,<br />
microinjection of the purified TFIIH complex into fibroblasts of other XP, XP/CS and<br />
TID patients appeared to induce selective correction of the NER defect of XP<br />
complementation groups Band -D and of TID complementation group A, but not of<br />
the other XP groups (7). Most likely, TFIIH is involved in local unwinding of the DNA<br />
duplex at the site of the DNA damage in the NER reaction and of the promoter in<br />
transcription initiation, executed by the DNA-dependent ATPase and DNA helicase<br />
activities associated with XPB and XPD (7, 8). Although most of the XP features can<br />
be explained on the basis of a NER deficiency, a number of symptoms of CS and TTD<br />
(such as the neurodysmyelination and the reduced content of cysteine-rich matrix<br />
proteins in the brittle TID hair) are difficult to rationalize in tenns of a NER<br />
impairment. The association of CS and TID phenotypes with mutations in the dually<br />
functional TFIIH has led to the hypothesis that the unusual symptoms of these diseases<br />
are due to subtle impainnent of the transcription function of the con·esponding proteins,<br />
leading to transcription insufficiencies for genes involved in the CS and TID<br />
symptoms. This 'repair/transcription-syndrome' concept also provides a rational for<br />
50 Chapter 3